A. Guerrero

774 total citations
33 papers, 655 citations indexed

About

A. Guerrero is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Physiology. According to data from OpenAlex, A. Guerrero has authored 33 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 10 papers in Pharmacology and 10 papers in Physiology. Recurrent topics in A. Guerrero's work include Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Inflammatory mediators and NSAID effects (9 papers). A. Guerrero is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Inflammatory mediators and NSAID effects (9 papers). A. Guerrero collaborates with scholars based in Spain. A. Guerrero's co-authors include J.P. De La Cruz, José Antonio González Correa, M.M. Arrebola, Javier Muñoz-Marín, Felipe Sánchez de la Cuesta, Juan Antonio López-Villodres, Josè L. Espartero, María Teresa Labajos Manzanares, M.A. Villalobos and Andrés Madrona and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Brain Research and Food Chemistry.

In The Last Decade

A. Guerrero

33 papers receiving 631 citations

Peers

A. Guerrero
István Bak Hungary
Nuray Arı Türkiye
Alex K. Harris United States
J. W. Baynes United States
R Sotníková Slovakia
Peter G. Foiles United States
A. Guerrero
Citations per year, relative to A. Guerrero A. Guerrero (= 1×) peers Pankaj K. Bagul

Countries citing papers authored by A. Guerrero

Since Specialization
Citations

This map shows the geographic impact of A. Guerrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Guerrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Guerrero more than expected).

Fields of papers citing papers by A. Guerrero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Guerrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Guerrero. The network helps show where A. Guerrero may publish in the future.

Co-authorship network of co-authors of A. Guerrero

This figure shows the co-authorship network connecting the top 25 collaborators of A. Guerrero. A scholar is included among the top collaborators of A. Guerrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Guerrero. A. Guerrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muñoz-Marín, Javier, J.P. De La Cruz, Juan Antonio López-Villodres, et al.. (2013). Hydroxytyrosyl alkyl ether derivatives inhibit platelet activation after oral administration to rats. Food and Chemical Toxicology. 58. 295–300. 21 indexed citations
2.
Guerrero, A., J.P. De La Cruz, Javier Muñoz-Marín, et al.. (2012). Neuroprotective effect of alkyl hydroxytyrosyl ethers in rat brain slices subjected to a hypoxia-reoxygenation model. Food Chemistry. 134(4). 2176–2183. 14 indexed citations
3.
Cruz, J.P. De La, Javier Muñoz-Marín, A. Guerrero, et al.. (2012). Antiplatelet effect of new lipophilic hydroxytyrosol alkyl ether derivatives in human blood. European Journal of Nutrition. 52(2). 591–599. 29 indexed citations
4.
López-Villodres, Juan Antonio, et al.. (2011). Lack of enantiomeric influence on the brain cytoprotective effect of ibuprofen and flurbiprofen. Naunyn-Schmiedeberg s Archives of Pharmacology. 384(2). 177–183. 5 indexed citations
5.
Correa, José Antonio González, M.M. Arrebola, Javier Muñoz-Marín, et al.. (2007). Gender differences in the effect of aspirin on retinal ischemia, prostanoid synthesis and nitric oxide production in experimental type 1-like diabetes. Vascular Pharmacology. 47(2-3). 83–89. 6 indexed citations
6.
Correa, José Antonio González, M.M. Arrebola, Javier Muñoz-Marín, et al.. (2006). Effects of aspirin plus alpha-tocopherol on brain slices damage after hypoxia-reoxygenation in rats with type 1-like diabetes mellitus. Neuroscience Letters. 400(3). 252–257. 9 indexed citations
7.
Correa, José Antonio González, et al.. (2006). Antioxidant and antiplatelet effects of the alpha-tocopherol–aspirin combination in type 1-like diabetic rats. Life Sciences. 79(15). 1405–1412. 13 indexed citations
8.
Correa, José Antonio González, M.M. Arrebola, Javier Muñoz-Marín, et al.. (2006). Effects of hypoxia reoxygenation in brain slices from rats with type 1‐like diabetes mellitus. Diabetes/Metabolism Research and Reviews. 22(5). 390–400. 10 indexed citations
9.
Correa, José Antonio González, M.M. Arrebola, A. Guerrero, et al.. (2005). Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood. Platelets. 16(3-4). 171–179. 17 indexed citations
10.
Guerrero, A., José Antonio González Correa, M.M. Arrebola, et al.. (2004). Antioxidant effects of a single dose of acetylsalicylic acid and salicylic acid in rat brain slices subjected to oxygen-glucose deprivation in relation with its antiplatelet effect. Neuroscience Letters. 358(3). 153–156. 28 indexed citations
11.
Correa, José Antonio González, M.M. Arrebola, A. Guerrero, et al.. (2004). Effects of triflusal on oxidative stress, prostaglandin production and nitric oxide pathway in a model of anoxia-reoxygenation in rat brain slices. Brain Research. 1011(2). 148–155. 12 indexed citations
12.
Cruz, J.P. De La, M.M. Arrebola, M.A. Villalobos, et al.. (2003). Influence of glucose concentration on the effects of aspirin, ticlopidine and clopidogrel on platelet function and platelet–subendothelium interaction. European Journal of Pharmacology. 484(1). 19–27. 20 indexed citations
13.
Cruz, J.P. De La, et al.. (2003). Differences in the effects of extended‐release aspirin and plain‐formulated aspirin on prostanoids and nitric oxide in healthy volunteers. Fundamental and Clinical Pharmacology. 17(3). 363–372. 9 indexed citations
14.
Mendez, Donna, et al.. (2003). The Effect of Propofol on the Interaction of Platelets with Leukocytes and Erythrocytes in Surgical Patients. Anesthesia & Analgesia. 96(3). 713–719. 20 indexed citations
15.
Cruz, J.P. De La, A. Guerrero, José Antonio González Correa, M.M. Arrebola, & Felipe Sánchez de la Cuesta. (2003). Antioxidant effect of acetylsalicylic and salicylic acid in rat brain slices subjected to hypoxia. Journal of Neuroscience Research. 75(2). 280–290. 39 indexed citations
16.
Arrebola, M.M., et al.. (2003). In Vitro Effects of Clopidogrel on the Platelet-Subendothelium Interaction, Platelet Thromboxane and Endothelial Prostacyclin Production, and Nitric Oxide Synthesis. Journal of Cardiovascular Pharmacology. 43(1). 74–82. 27 indexed citations
17.
Cruz, J.P. De La, et al.. (2002). Nitric Oxide-cGMP and Prostacyclin-cAMP Pathways in Patients with Type II Diabetes and Different Types of Retinopathy. Pathophysiology of Haemostasis and Thrombosis. 32(1). 25–32. 8 indexed citations
19.
Cruz, J.P. De La, M.M. Arrebola, A. Guerrero, & Felipe Sánchez de la Cuesta. (2002). Influence of nitric oxide on the in vitro antiaggregant effect of ticlopidine. Vascular Pharmacology. 38(3). 183–186. 8 indexed citations
20.
Cruz, J.P. De La, et al.. (2001). Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans. European Journal of Clinical Pharmacology. 57(11). 775–780. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026